期刊文献+

各种类型过敏性结膜炎患者应用奥洛他定滴眼液联合双氯芬酸钠滴眼液治疗的临床效果评价 被引量:17

下载PDF
导出
摘要 目的探究分析双氯芬酸钠滴眼液联合奥洛他定滴眼液对各种类型过敏性结膜炎的治疗效果。方法 118例过敏性结膜炎患者,随机分为对照组和试验组,各59例。对照组应用奥洛他定滴眼液进行治疗,试验组在对照组基础上加用双氯芬酸钠滴眼液进行治疗,观察并比较两组患者治疗14 d后的症状和体征总得分、治疗效果。结果试验组治疗14 d后的症状和体征总得分为(1.32±0.37)分,明显低于对照组的(8.07±2.08)分,试验组治疗后的总有效率为72.88%,明显高于对照组的45.76%,差异有统计学意义(P<0.05)。结论对于各种类型过敏性结膜炎,应用奥洛他定滴眼液联合双氯芬酸钠滴眼液治疗有较好的疗效,能够有效缓解患者的症状,可以在临床上推广运用。
作者 盛焱
出处 《中国实用医药》 2015年第29期133-134,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献41

  • 1刘祖国,姚勇,孙秉基,孙兴怀,谢汉平,王红,万修华,崔敏,陈龙山,张梅.过敏性结膜炎的临床特点[J].中国实用眼科杂志,2004,22(9):694-697. 被引量:94
  • 2李凤鸣.中华眼科学.(中册)第2版.北京:人民卫生出版社,2005:2165-2166
  • 3Abelson MB,Gomes PJ,Pasquine T,et al.Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis[J] .Allergy Asthma Proc,2007,28(4):427-433.
  • 4Swamy BN,Chilov M,Mclellan K,et al.Topical non-steroidal anti inflammatorydrugs in allergic conjunctivitis:meta-analysis of randomizedtrial data[J] .Ophthalmic Epidemiol,2007,14(5):311-319.
  • 5Mah FS,O'Brien T,Kim T,et al.Evaluation of the effects of olopatadine ophthalmic solution 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye[J] .Curr Med Res Opin,2008,24(2):441-447.
  • 6Manzouri B, Flynn TH, Larkin F, et al. Pharmacotherapy of aller- gic eye disease [J]. Expert Opin Pharmacother, 2006, 7 (9): 1191-1200.
  • 7Leonardi S, Miraglia del Giudice M, La Rosa M, et al. Atopic disease, immune system, and the environment[J]. Allergy Asth- ma Proc,2007,28(4) :410-417.
  • 8Leonardi A, Motterle L, Bortolotti M. Allergy and the eye[J]. Clin Exp Immunol,2008,153:17-21.
  • 9Bilkhu PS, Wolffsohn JS, Naroo SA. A review of non-pharmaco- logical and pharmacological management of seasonal and peren- nial allergic conjunctivitis[J]. Cont Lens Anterior Eye,2012,35 (1):9-16.
  • 10Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy:a schematic approach to different clinical entities [J]. Curr Opin Allergy Clin Immunol,2007,7(5):429-435.

共引文献72

同被引文献119

  • 1刘祖国,肖启国.过敏性结膜炎的诊治[J].中华眼科杂志,2004,40(7):500-502. 被引量:63
  • 2刘祖国,姚勇,孙秉基,孙兴怀,谢汉平,王红,万修华,崔敏,陈龙山,张梅.过敏性结膜炎的临床特点[J].中国实用眼科杂志,2004,22(9):694-697. 被引量:94
  • 3马素红.中药联合色甘酸钠眼液治疗过敏性结膜炎35例观察[J].中国药物经济学,2013,8(5):313-314.李晓华,李锦,王勤.中西医结合治疗变态反应性结膜炎43例疗效观察[J].河北中医,2013,35(11):1678-1700.
  • 4范虹.过敏性结膜炎的临床特点及与其他过敏性疾病的相关性调查分析[J].中外健康文摘2010,7(28):28-32.
  • 5Sy H,Bielory L.Atopic keratoconjunctivitis[J].Allergy Asthma Proc,2013,34(5):33-41.
  • 6Schmid KL,Schmid LM,Ocular allergy:causes and therapeutic options[J].Clin Exp Optom,2000,83(6):257-270.
  • 7Ohashi Y,Ebihara N,Fujishima H,et al.A randomized,placebocontrolled clinical trial of tacrolimus ophthalmic suspen- sion 0.1% in severe allergic conjunctivitis[J].J Ocul Pharmacol Ther,2010,26(2):165-174.
  • 8Goldstein M H, Tubridy K L, Agahigian J, et al.A phase 2 exploratory study of a novel interleukin-1 receptor inhibitor ( EBI-005 ) in the treatment of moderate-to-severe allerglc conjunctivitis[J].Eye Contact Lens, 2015, 41 ( 3 ) : 145-155.
  • 9Chigbu D I, Coyne A M.Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis[J].Clin Ophthalmol, 2015, 8 ( 9 ) : 1215-1225.
  • 10McLaurin E B, Marsico N P, Ackerman S L, et al.Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials[J].Adv Ther, 2014," 31, ( 10 ) : 1059-1071.

引证文献17

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部